Envelope protein

Envelope protein

Envelope protein Informations sur la molécule

Molecule Name
Recombinant envelope protein
Alias de la molécule
Envelope protein,Env polyprotein,Envelope glycoprotein,env
Drug Development Progress
Nombre de médicaments cliniques6
Nombre de médicaments commercialisés1
Phase de R&D la plus avancéeApproved
Alias de la cible
env,Submitted name: Recombinant envelope protein,Viral Envelope Proteins
Contexte de la molécule
The SARS-CoV-2 is composed of a double-layered lipid envelope, including Spike glycoprotein (S), Envelope protein (E), Membrane glycoprotein (M), and Nucleocapsid protein (Nucleocapsid protein, N). Among them, The amino acid sequence of the SARS-CoV-2 envelope protein is 95% identical of the SARS envelope protein.

Envelope protein Liste de produits

Species
  • pHERV-W(1)
  • SARS-CoV-2(1)
Tag
  • His Tag(1)
  • His Tag & GST Tag(1)
Host
  • E. coli(1)
  • HEK293(1)
Conjugate
  • Unconjugated(2)
Grade
  • RUO(2)
Low Endotoxin
  • No(2)
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
Envelope protein
SARS-CoV-2 (COVID-19) Envelope protein, GST,His Tag
SARS-CoV-2
E. coli
SDS-PAGE

$360.00

100ug
Envelope protein
pHERV-W Envelope protein, His Tag
pHERV-W
HEK293
SDS-PAGE

$336.00

100ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Targeting HIV-1 Env gp140 antibodiesPhase 2 ClinicalNational Institute Of Allergy And Infectious Diseases (Niaid)
HIV Infections
Details
TemelimabGNN-001; GENHP-01; GNbAC-1Phase 2 ClinicalGeneuro Sa
Diabetes Mellitus, Type 1; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Post-Acute COVID-19 Syndrome
Details
VIS-513VIS-513; Ab-513Phase 2 ClinicalOtsuka Pharmaceutical Co Ltd, Serum Institute Of India Ltd, Visterra Inc
Dengue
Details
PGDM-1400PGDM-1400; PGDM1400LSPhase 2 ClinicalInternational Aids Vaccine Initiative
Acquired Immunodeficiency Syndrome; HIV Infections; Sexually Transmitted Diseases, Viral
Details
MGD-020MGD020Phase 1 ClinicalMacrogenics Inc
HIV Infections
Details
GS-8588GS-8588Phase 1 ClinicalGilead Sciences Inc
HIV Infections
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
TecovirimatSIGA-246; ST-246ApprovedSiga Technologies IncTpoxx, ArestvyrUnited StatesSmallpoxSiga Technologies Inc2018-07-13
Cowpox; Monkeypox; Orthopoxvirus Infection; Poxviridae Infections; Smallpox; Vaccinia
Details
Customer Reviews